Securities Lawsuits Set October Deadlines for Three Firms
Law firms have announced or reminded investors about securities class actions involving GoDaddy, Aardvark Therapeutics and ARS Pharmaceuticals. GoDaddy investors who purchased shares between September 3, 2025, and February 24, 2026, must seek lead-plaintiff status by October 20, 2026. The Aardvark complaint covers investors who bought securities in or traceable to the company’s February 2025 initial public offering, or between February 13, 2025, and May 14, 2026; it alleges that the company misrepresented the safety and prospects of its ARD-101 treatment. ARS Pharmaceuticals investors who purchased securities between March 9 and June 24, 2026, face an October 5, 2026, lead-plaintiff deadline. The notices say eligible investors may participate without upfront costs, while the allegations have not been proven in court.